title: Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice.
abstract: Since kringle (K)5, not present in the angiostatin molecule, was shown to be a key functional domain possessing potent antiangiogenic activity, we have evaluated a new plasminogen-derived fragment, consisting of the N-terminal part of human plasminogen, that included the complete secondary structure of K1-5 (aa 1-566). In contrast to other fragments described to date, K1-5 includes cysteine residues at positions 543, 555 and 560 allowing the formation of the three disulfide bonds lying within K5. Vascular endothelial cell proliferation and migration assays revealed that a replication-defective adenovirus (AdK1-5(1-566)), expressing K1-5 (aa 1-566), was dose dependently more potent that AdK1-3(1-354), an adenovirus that expresses only the first three kringles. In contrast to AdK1-3(1-354), a single intratumoral injection of AdK1-5(1-566) into MDA-MB-231 breast human carcinoma tumors was followed by a total regression of 40% of the tumor and by significant arrest of tumor growth (90%), which was correlated with a drastic decrease of functional neovascularization into the tumors. Furthermore, systemic delivery of AdK1-5(1-566) in mice inhibited the lung invasion of melanoma B16-F10 cells by 87%. Our findings provide evidence that the full kringles of plasminogen (aa 1-566) may be much more potent than K1-3 (aa 1-354), for the suppression of angiogenesis, tumor growth and metastatic dissemination.
authors.affiliation: Le Centre National de la Recherche Scientifique, Unité Mixte de Recherche (UMR) 8121, Institut Gustave Roussy, Villejuif Cedex, France.
authors.forename: A
authors.initials: A
authors.lastname: Galaup
authors.forename: C
authors.initials: C
authors.lastname: Magnon
authors.forename: V
authors.initials: V
authors.lastname: Rouffiac
authors.forename: P
authors.initials: P
authors.lastname: Opolon
authors.forename: D
authors.initials: D
authors.lastname: Opolon
authors.forename: N
authors.initials: N
authors.lastname: Lassau
authors.forename: T
authors.initials: T
authors.lastname: Tursz
authors.forename: M
authors.initials: M
authors.lastname: Perricaudet
authors.forename: F
authors.initials: F
authors.lastname: Griscelli
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage*; D006801:Humans; D018082:Kringles / Q000235:genetics*; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary / Q000628:therapy; D008545:Melanoma / Q000473:pathology / Q000628:therapy; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009389:Neovascularization, Pathologic; D010958:Plasminogen / Q000235:genetics*; D011897:Random Allocation; D014183:Transplantation, Heterologous
chemical_list: D010958:Plasminogen